Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021
09:05pm, Thursday, 10'th Feb 2022 PR Newswire
SAN DIEGO, Feb. 10, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2021, which include the consolidated financial results of GRAIL. Fourth quarter consolidated results: Revenue of $1,198 million, a 26%
Illumina's (ILMN) CEO Francis deSouza on Q4 2021 Results - Earnings Call Transcript
08:47pm, Thursday, 10'th Feb 2022
Illumina's (ILMN) CEO Francis deSouza on Q4 2021 Results - Earnings Call Transcript
Illumina (ILMN) Q4 Earnings and Revenues Beat Estimates
07:10pm, Thursday, 10'th Feb 2022
Illumina (ILMN) delivered earnings and revenue surprises of 50% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
01:29pm, Thursday, 10'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Merck Announces Publication Of Positive Late-Stage Data For Keytruda-Chemo Combo In Breast Cancer
Merc
A Gene Sequencing Pioneer Battles Over What It Can Buy
10:00am, Thursday, 10'th Feb 2022 New York Times
Is Illumina, a gene-sequencing powerhouse, trying to speed innovation in the field of cancer blood tests or thwart it with an acquisition?
All eyes on Illumina Q4 earnings amid positive FY2022 outlook (NASDAQ:ILMN)
04:16pm, Wednesday, 09'th Feb 2022 Seeking Alpha
Illumina (NASDAQ:ILMN) is scheduled to announce Q4 earnings results on Thursday, February 10th, after market close.The consensus EPS Estimate is $0.49 (-59.8% Y/Y) and the consensus
Is a Surprise Coming for Illumina (ILMN) This Earnings Season?
02:13pm, Wednesday, 09'th Feb 2022 Zacks Investment Research
Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Wednesday Morning's 14 Tech Stock Movers Include Amgen, Starbucks and Zoom
11:04am, Wednesday, 09'th Feb 2022
Tech stocks got off to a positive start Wednesday morning. The Nasdaq traded up about 1.3%, the S&P 500 was up 1.04% and the Dow traded 0.7% higher shortly after the opening bell.
Is a Surprise Coming for Illumina (ILMN) This Earnings Season?
10:45am, Wednesday, 09'th Feb 2022
Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Illumina (ILMN) to Address Nasopharynx Cancer With New Pact
12:45pm, Monday, 07'th Feb 2022 Zacks Investment Research
Illumina's (ILMN) recent collaboration will fuel initiatives that enhance health outcomes for people living with nasopharynx cancer and advance the development of personalized treatment.
Illumina (ILMN) to Address Nasopharynx Cancer With New Pact
09:15am, Monday, 07'th Feb 2022
Illumina's (ILMN) recent collaboration will fuel initiatives that enhance health outcomes for people living with nasopharynx cancer and advance the development of personalized treatment.
Disney, Chipotle, Pfizer, Twitter, Coca-Cola, and Other Stocks for Investors to Watch This Week
08:00pm, Sunday, 06'th Feb 2022 Barron''s
Fourth-quarter earning season continues with reports from Chipotle, Pfizer, Disney, CVS, Toyota, Twitter, Coca-Cola, Illumina, PepsiCo, and more. Plus, January CPI inflation data.
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
01:22pm, Sunday, 06'th Feb 2022 Benzinga
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some bi
European stocks slide as investors weigh up central bank meetings, strong U.S. jobs data
02:37pm, Friday, 04'th Feb 2022 MarketWatch
European stocks are set to finish the week with a loss, as investors try to gauge what's next for central banks.
Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
08:01pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
